Abdominal adiposity and physical fitness are major determinants of the age associated decline in stimulated GH secretion in healthy adults

被引:131
作者
Vahl, N
Jorgensen, JOL
Jurik, AG
Christiansen, JS
机构
[1] AARHUS UNIV, AARHUS KOMMUNE HOSP, MED DEPT ENDOCRINOL & DIABET M, DK-8000 AARHUS C, DENMARK
[2] AARHUS UNIV, AARHUS KOMMUNE HOSP, DEPT RADIOL, DK-8000 AARHUS C, DENMARK
关键词
D O I
10.1210/jc.81.6.2209
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Growth hormone (GH) secretion is reduced with age in normal subjects. Aging is furthermore associated with a decline in lean body mass and an increase in relative adiposity, and overt obesity is a negative determinant of GH secretion in all age groups. We tested the hypothesis that differences in body composition and physical fitness rather than age determine stimulated GH secretion in healthy adults. Forty-two clinically nonobese adults [22 women and 20 men, mean age 39.4 yr (range 27-59), mean +/- SE body mass index (BMI) = 23.9 0.5 kg/m(2)] underwent 2 GH stimulation tests (arginine and clonidine), determination of maximal oxygen consumption (VO2-max), and a number of anthropometric measurements: body mass index (BMI), waist to hip (W/H)-ratio, intraabdominal fat and thigh muscle to fat (M/F)-ratio (computed tomography scan), total body fat, and lean body mass (DEXA scan). Peak GH levels were lower with clonidine [mean +/- SE (mu g/L): 9.79 +/- 1.29 (arginine) vs. 3.56 +/- 0.57 (clonidine) (P < 0.001)]. Arginine-stimulated GH peak levels correlated negatively with indices of adiposity and age [intraabdominal fat:r = -0.72, P < 0.001; W/H ratio:r = -0.58, P < 0.001; age: r = -0.54, P < 0.001], and positively with VO2-max [r = 0.60, P < 0.001]. Clonidine-stimulated GH peak correlated negatively with intraabdominal fat [r = -0.60, P < 0.001] and age [r = -0.46, P = 0.008]. Multiple linear regression revealed multicollinearity among several of the independent variables. In all equations abdominal adiposity and physical fitness, rather than age, contributed significantly to predict changes in arginine stimulated GH secretion. Intraabdominal fat was a more important determinant of the clonidine evoked GH response than age. In clinically nonobese, healthy adults relative adiposity, in particular in the abdominal region, is a major negative determinant of stimulated GH secretion, and physical fitness is an important positive predictor. The cause-effect relationship of these observations remains to be elucidated, but our findings may have clinical implications in the diagnosing of GH-deficiency in adults.
引用
收藏
页码:2209 / 2215
页数:7
相关论文
共 40 条
[1]  
AASTRAND I, 1960, ACTA PHYSL SCAN S169, V49, P9
[2]   ARGININE STIMULATES GROWTH-HORMONE SECRETION BY SUPPRESSING ENDOGENOUS SOMATOSTATIN SECRETION [J].
ALBAROTH, J ;
MULLER, OA ;
SCHOPOHL, J ;
VONWERDER, K .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1988, 67 (06) :1186-1189
[3]   TREATMENT OF ADULTS WITH GROWTH-HORMONE (GH) DEFICIENCY WITH RECOMBINANT HUMAN GH [J].
BENGTSSON, BA ;
EDEN, S ;
LONN, L ;
KVIST, H ;
STOKLAND, A ;
LINDSTEDT, G ;
BOSAEUS, I ;
TOLLI, J ;
SJOSTROM, L ;
ISAKSSON, OGP .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 76 (02) :309-317
[4]  
CHIGO E, 1994, J ENDOCRINOL INVEST, V17, P113
[5]   INSULIN REGULATION OF INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-1 IN OBESE AND NONOBESE HUMANS [J].
CONOVER, CA ;
LEE, PDK ;
KANALEY, JA ;
CLARKSON, JT ;
JENSEN, MD .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 74 (06) :1355-1360
[6]   CHOLINERGIC RECEPTOR ACTIVATION BY PYRIDOSTIGMINE RESTORES GROWTH-HORMONE (GH) RESPONSIVENESS TO GH-RELEASING HORMONE ADMINISTRATION IN OBESE SUBJECTS - EVIDENCE FOR HYPOTHALAMIC SOMATOSTATINERGIC PARTICIPATION IN THE BLUNTED GH RELEASE OF OBESITY [J].
CORDIDO, F ;
CASANUEVA, FF ;
DIEGUEZ, C .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1989, 68 (02) :290-293
[7]   EFFECT OF CENTRAL CHOLINERGIC NEUROTRANSMISSION ENHANCEMENT BY PYRIDOSTIGMINE ON THE GROWTH-HORMONE SECRETION ELICITED BY CLONIDINE, ARGININE, OR HYPOGLYCEMIA IN NORMAL AND OBESE SUBJECTS [J].
CORDIDO, F ;
DIEGUEZ, C ;
CASANUEVA, FF .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990, 70 (05) :1361-1370
[8]   HUMAN GROWTH-HORMONE AND HUMAN AGING [J].
CORPAS, E ;
HARMAN, SM ;
BLACKMAN, MR .
ENDOCRINE REVIEWS, 1993, 14 (01) :20-39
[9]   CLINICAL ASPECTS OF GROWTH-HORMONE DEFICIENCY IN ADULTS [J].
DEBOER, H ;
BLOK, GJ ;
VANDERVEEN, EA .
ENDOCRINE REVIEWS, 1995, 16 (01) :63-86
[10]   EFFECT OF AGE ON GROWTH-HORMONE SECRETION IN MAN [J].
DUDL, RJ ;
ENSINCK, JW ;
PALMER, HE ;
WILLIAMS, RH .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1973, 37 (01) :11-16